Singapore O&G (SGX:1D8) ROCE % : 20.39% (As of Dec. 2021)

View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Singapore O&G's annualized ROCE % for the quarter that ended in Dec. 2021 was 20.39%.

Singapore O&G ROCE % Historical Data

The historical data trend for Singapore O&G's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore O&G ROCE % Chart

Singapore O&G Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

22.29

24.75

1.92

26.19

22.44

Singapore O&G Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
ROCE %	Get a 7-Day Free Trial											-23.48	23.08	29.05	24.97	20.39

Singapore O&G ROCE % Calculation

Singapore O&G's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	9.978	/	( ( (57.86 - 12.872)	+	(57.786 - 13.836) )	/ 2 )
	=	9.978	/	( (44.988	+	43.95)	/ 2 )
	=	9.978	/	44.469
	=	22.44 %

Singapore O&G's ROCE % of for the quarter that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2021 )		(Q: Jun. 2021 )		(Q: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2021 )		(Q: Jun. 2021 )		(Q: Dec. 2021 )
	=	8.912	/	( ( (53.764 - 10.279)	+	(57.786 - 13.836) )	/ 2 )
	=	8.912	/	( ( 43.485	+	43.95 )	/ 2 )
	=	8.912	/	43.7175
	=	20.39 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2021) EBIT data.

Singapore O&G (SGX:1D8) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Singapore O&G ROCE % Related Terms

Thank you for viewing the detailed overview of Singapore O&G's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore O&G (SGX:1D8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007

Website

https://www.sog.com.sg

Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines